Coral Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
445.65
11 (2.53%)
BSENSE

Feb 01

BSE+NSE Vol: 2.23 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 476417,
    "name": "Coral Labs.",
    "stock_name": "Coral Labs.",
    "full_name": "Coral Laboratories Ltd",
    "name_url": "stocks-analysis/coral-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "445.65",
    "chg": 11,
    "chgp": "2.53%",
    "dir": 1,
    "prev_price": "434.65",
    "mcapval": "164.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524506,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE683E01017",
    "curr_date": "Feb 01",
    "curr_time": "",
    "bse_nse_vol": "2.23 k",
    "exc_status": "Active",
    "traded_date": "Feb 01, 2026",
    "traded_date_str": "2026 02 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/coral-labs-476417-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Coral Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-strong-sell-3803933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_mojoScore_3803933.png",
        "date": "2026-01-25 10:10:42",
        "description": "Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Coral Laboratories Ltd Stock Hits 52-Week Low at Rs.415",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-at-rs415-3798539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_priceRelatedfactors_3798539.png",
        "date": "2026-01-21 11:29:02",
        "description": "Shares of Coral Laboratories Ltd have declined to a fresh 52-week low of Rs.415 on 21 Jan 2026, marking a significant downturn amid persistent underperformance relative to the broader market and sector indices."
      },
      {
        "title": "Coral Laboratories Ltd Stock Falls to 52-Week Low of Rs.419",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-falls-to-52-week-low-of-rs419-3790066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_priceRelatedfactors_3790066.png",
        "date": "2026-01-12 12:00:17",
        "description": "Coral Laboratories Ltd has reached a new 52-week low of Rs.419, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and valuation metrics."
      },
      {
        "title": "Coral Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-sell-3789639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_mojoScore_3789639.png",
        "date": "2026-01-12 10:10:52",
        "description": "Coral Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Coral Laboratories Ltd’s 1.00% Weekly Gain Masks Underlying Weaknesses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltds-100-weekly-gain-masks-underlying-weaknesses-3780124",
        "imagepath": "",
        "date": "2026-01-04 12:44:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Stock opens at Rs.446.85, declines 1.11%</p>\n                    <p><strong>30 Dec 2025:</strong> Further decline to Rs.437.40 (-2.11%)</p>\n                    <p><strong>31 Dec 2025:</strong> Coral Laboratories hits 52-week low of Rs.429</p>\n                    <p><strong>1 Jan 2026:</strong> Downgraded to Strong Sell by MarketsMOJO</p>\n                    <p><strong>2 Jan 2026:</strong> Stock rebounds to Rs.456.35 (+3.32%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.446.85</div></div>\n                    <div class=\"stat-item\"..."
      },
      {
        "title": "Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3777106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_mojoScore_3777106.png",
        "date": "2026-01-01 08:10:27",
        "description": "Coral Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 31 Dec 2025. This revision reflects deteriorating financial performance, unfavourable valuation metrics, and a shift towards bearish technical indicators, signalling heightened risk for investors."
      },
      {
        "title": "Coral Laboratories Ltd Stock Falls to 52-Week Low of Rs.429",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-falls-to-52-week-low-of-rs429-3776281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CoralLaboratori_priceRelatedfactors_3776281.png",
        "date": "2025-12-31 11:17:50",
        "description": "Coral Laboratories Ltd touched a fresh 52-week low of Rs.429 today, marking a significant decline amid ongoing challenges in its financial performance and market positioning. Despite a modest intraday recovery, the stock remains below all key moving averages, reflecting persistent downward pressure."
      },
      {
        "title": "Why is Coral Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-coral-laboratories-ltd-fallingrising-3771680",
        "imagepath": "",
        "date": "2025-12-27 00:37:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Volatility</strong></p>\n<p>Despite opening the day with a positive gap of 3.14%, the stock failed to sustain its early momentum. It reached an intraday high of ₹496.6, reflecting initial optimism, but subsequently declined sharply to an intraday low of ₹447, marking a 7.17% drop from the high. The wide trading range of ₹49.6 and an intraday volatility of 5.26% underscore the stock’s turbulent session. Notably, the weighted average price indicates that a larger volume of shares traded closer to the lower end of the day’s price range, suggesting selling pressure dominated as the session progressed.</p>\n<p><strong>Technical Indicators and Moving Averages</strong></p>\n<p>Coral Laboratories is currently trading below all key moving averages, including the 5-day, 20-day,..."
      },
      {
        "title": "Coral Laboratories: Analytical Revision Highlights Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-upgraded-to-sell-on-technical-improvements-despite-weak-financials-3766638",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CoralLaboratori_mojoScore_3766638.png",
        "date": "2025-12-23 08:36:47",
        "description": "Coral Laboratories has undergone a revision in its evaluation metrics reflecting a nuanced market assessment shaped by recent financial results, valuation considerations, and technical indicators. This article analyses the key factors influencing the updated perspective on the pharmaceutical company’s stock performance and outlook."
      }
    ],
    "total": 144,
    "sid": "476417",
    "stock_news_url": "https://www.marketsmojo.com/news/coral-laboratories-476417"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Please find attached herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 furnished by M/s. MUF Intime India Private Limited (formerly known as Link Intime India Private Limited) the Registrar and Share Transfer agent of the Company for the quarter ended December 31 2025. You are requested to take the same on record.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Dec-2025",
      "details": "Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations 2015 Reg: Intimation regarding Resignation of Company Secretary and Compliance Officer of the Company In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that Mrs. Dhwani Desai has tendered her resignation from the post of Company Secretary and Compliance Officer of the Company to pursue another career opportunity.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Dec-2025",
      "details": "Dear Sir/Madam This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and as per the Companys Code of Conduct to regulate monitor and report trading by insiders (Code) the Trading Window for dealing in the securities of the Company will be closed for all the Designated Persons and their relatives from Thursday January 01 2026 till 48 (forty eight) hours after declaration of unaudited standalone financial results for the quarter and nine months ended December 31 2025. The trading window shall open after 48 hours of declaration of the said results. The date of the Board meeting to consider inter alia unaudited standalone financial results for the quarter and nine months ended December 31 2025 shall be intimated separately in due course. The same is being informed to the Designated Persons and Connected Persons in accordance with the Code of Conduct. Kindly take the same on your record.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Coral Laboratories Ltd has declared <strong>15%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Coral Laboratories Ltd’s 1.00% Weekly Gain Masks Underlying Weaknesses

2026-01-04 12:44:00

Key Events This Week

29 Dec 2025: Stock opens at Rs.446.85, declines 1.11%

30 Dec 2025: Further decline to Rs.437.40 (-2.11%)

31 Dec 2025: Coral Laboratories hits 52-week low of Rs.429

1 Jan 2026: Downgraded to Strong Sell by MarketsMOJO

2 Jan 2026: Stock rebounds to Rs.456.35 (+3.32%)

stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Jan-2026 | Source : BSE

Please find attached herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 furnished by M/s. MUF Intime India Private Limited (formerly known as Link Intime India Private Limited) the Registrar and Share Transfer agent of the Company for the quarter ended December 31 2025. You are requested to take the same on record.

Announcement under Regulation 30 (LODR)-Change in Management

30-Dec-2025 | Source : BSE

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations 2015 Reg: Intimation regarding Resignation of Company Secretary and Compliance Officer of the Company In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that Mrs. Dhwani Desai has tendered her resignation from the post of Company Secretary and Compliance Officer of the Company to pursue another career opportunity.

Closure of Trading Window

23-Dec-2025 | Source : BSE

Dear Sir/Madam This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and as per the Companys Code of Conduct to regulate monitor and report trading by insiders (Code) the Trading Window for dealing in the securities of the Company will be closed for all the Designated Persons and their relatives from Thursday January 01 2026 till 48 (forty eight) hours after declaration of unaudited standalone financial results for the quarter and nine months ended December 31 2025. The trading window shall open after 48 hours of declaration of the said results. The date of the Board meeting to consider inter alia unaudited standalone financial results for the quarter and nine months ended December 31 2025 shall be intimated separately in due course. The same is being informed to the Designated Persons and Connected Persons in accordance with the Code of Conduct. Kindly take the same on your record.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Coral Laboratories Ltd has declared 15% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available